Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 195-200

  Salas, Sébastien ^a   Deville, Jean Laurent ^a   Giorgi, Roch ^a   Pignon, Thierry ^a   Bagarry, Danielle ^a   Barrau, Karine ^b   Zanaret, Michel ^a   Giovanni, Antoine ^a   Bourgeois, Aude ^a   Favre, Roger ^a   Duffaud, Florence ^a  

^a TIMONE HOSPITAL   (France)

^b Laboratoire de Santé Publique   (France)

Author keywords

Head and neck carcinoma; Nutritional factors; Radio chemotherapy; Response; Survival

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CARBOPLATIN; FLUOROURACIL; OROSOMUCOID; PREALBUMIN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

EID: 43049161309     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.02.011     Document Type: Article

References (49)

1. F. Denis P. Garaud E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
2. S. El-Sayed N. Nelson Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials J Clin Oncol 14 1996 838 847
3. J.P. Pignon J. Bourhis C. Domenge L. Designe Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949 955
4. D.J. Adelstein Y. Li G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
5. G. Calais M. Alfonsi E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
6. A.A. Forastiere H. Goepfert M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
7. T.G. Wendt G.G. Grabenbauer C.M. Rodel Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study J Clin Oncol 16 1998 1318 1324
8. S. Bieri S.M. Bentzen P. Huguenin Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies Strahlenther Onkol 179 2003 390 395
9. A. Munshi M.B. Pandey T. Durga K.C. Pandey S. Bahadur B.K. Mohanti Weight loss during radiotherapy for head and neck malignancies: what factors impact it? Nutr Cancer 47 2003 136 140
10. M.E. Beaver K.E. Matheny D.B. Roberts J.N. Myers Predictors of weight loss during radiation therapy Otolaryngol Head Neck Surg 125 2001 645 648
11. L.A. Newman F. Vieira V. Schwiezer Eating and weight changes following chemoradiation therapy for advanced head and neck cancer Arch Otolaryngol Head Neck Surg 124 1998 589 592
12. J. Lees Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre Eur J Cancer Care 8 1999 133 136
13. W. Duncan R.H. MacDougall G.R. Kerr D. Downing Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer Radiother Oncol 41 1996 203 207
14. A.G. Robertson C. Robertson C. Perone Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis Radiother Oncol 48 1998 165 173
15. M.H. Kaplan A.R. Feinstein The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus J Chronic Dis 27 1974 387 404
16. J.F. Piccirillo A.R. Feinstein Clinical symptoms and comorbidity: significance for the prognostic classification of cancer Cancer 77 1996 834 842
17. G.B. Brookes Nutritional status – a prognostic indicator in head and neck cancer Otolaryngol Head Neck Surg 93 1985 69 74
18. K. Sako J.M. Lore S. Kaufman M.S. Razack V. Bakamjian P. Reese Parenteral hyperalimentation in surgical patients with head and neck cancer: a randomized study J Surg Oncol 16 1981 391 402
19. J.J. Reilly Does nutrition management benefit the head and neck cancer patient? Oncology (Williston Park, N.Y) 4 1990 105 115 discussion 115–116
20. C. Caldani A. Thyss M. Schneider G. Milano L. Buray F. Demard Orosomucoid:prealbumin ratio – a marker of the host-tumor relationship in head and neck cancer Eur J Cancer Clin Oncol 24 1988 653 657
21. S. van Bokhorst-de van der P.A. van Leeuwen D.J. Kuik The impact of nutritional status on the prognoses of patients with advanced head and neck cancer Cancer 86 1999 519 527
22. Y. Ingenbleek Y.A. Carpentier A prognostic inflammatory and nutritional index scoring critically ill patients. International journal for vitamin and nutrition research Int Z Vit Ernahrungsforsch 55 1985 91 101
23. K.L. Vehe R.O. Brown D.A. Kuhl B.A. Boucher R.W. Luther K.A. Kudsk The prognostic inflammatory and nutritional index in traumatized patients receiving enteral nutrition support J Am Coll Nutr 10 1991 355 363
24. K.A. Nelson D. Walsh The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease J Pain Sympt Manag 24 2002 424 428
25. J.M. Okamura J.M. Miyagi K. Terada Y. Hokama Potential clinical applications of C-reactive protein J Clinical Lab Anal 4 1990 231 235
26. S.P. Ballou I. Kushner C-reactive protein and the acute phase response Adv Intern Med 37 1992 313 336
27. P. Geissbuhler B. Mermillod C.H. Rapin Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years J Pain Sympt Manag 20 2000 93 103
28. A.J. Staal-van den Brekel M.A. Dentener A.M. Schols W.A. Buurman E.F. Wouters Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients J Clin Oncol 13 1995 2600 2605
29. D.C. McMillan T. Preston W.S. Watson Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer Br J Surg 81 1994 1011 1014
30. A. Vigano E. Bruera G.S. Jhangri S.C. Newman A.L. Fields M.E. Suarez-Almazor Clinical survival predictors in patients with advanced cancer Arch Intern Med 160 2000 861 868
31. Y. Hirasawa N. Kohno A. Yokoyama K. Kondo K. Hiwada M. Miyake Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer Am J Respirat Crit Care Med 161 2000 589 594
32. D. Parker C. Bradley S.M. Bogle Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer Br J Obst Gynaecol 101 1994 888 893
33. M.N. Sirott D.F. Bajorin G.Y. Wong Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis Cancer 72 1993 3091 3098
34. L. Wyld E. Gutteridge S.E. Pinder Prognostic factors for patients with hepatic metastases from breast cancer Br J Cancer 89 2003 284 290
35. J. Bourhis F. Rivera R. Mesia Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck J Clin Oncol 24 2006 2866 2872
36. V.J. Lanzotti D.R. Thomas L.E. Boyle T.L. Smith E.A. Gehan M.L. Samuels Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria Cancer 39 1977 303 313
37. H. Pedersen H.S. Hansen C. Cederqvist J. Lober The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer Acta Chirurg Scand 148 1982 363 366
38. W.D. Dewys C. Begg P.T. Lavin Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group Am J Med 69 1980 491 497
39. T. Wiggers J.W. Arends A. Volovics Regression analysis of prognostic factors in colorectal cancer after curative resections Dis Colon Rectum 31 1988 33 41
40. A. Phillips A.G. Shaper P.H. Whincup Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes Lancet 2 1989 1434 1436
41. W.J. Meijerink M.F. von Meyenfeldt M.M. Rouflart P.B. Soeters Efficacy of perioperative nutritional support Lancet 340 1992 187 188
42. M. Werner Serum protein changes during the acute phase reaction Clin Chim Acta Int J Clin Chem 25 1969 299 305
43. J.C. Charet J. Watine A. Lepretre C. Raimbault P. Charet Orosomucoid: prealbumin ratio in the monitoring of lung cancer Clin Biochem 29 1996 287 290
44. C. Caldani G. Milano M. Schneider A. Thyss G. Lesbats C.M. Lalanne [Host-tumor relationship as a function of the orosomucoid-prealbumin ratio] Bull Cancer 70 1983 1 8
45. J.H. Lee M. Machtay L.D. Unger Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck Arch Otolaryngol Head Neck Surg 124 1998 871 875
46. J.S. Scolapio P.R. Spangler M.M. Romano M.P. McLaughlin J.R. Salassa Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile? J Clin Gastroenterol 33 2001 215 217
47. D.W. Nixon S.B. Heymsfield A.E. Cohen Protein-calorie undernutrition in hospitalized cancer patients Am J Med 68 1980 683 690
48. M. Baghi M. Hambek A. May A. Radeloff W. Gstoettner R. Knecht Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck Anticancer Res 26 2006 559 563
49. H. Katori M. Tsukuda Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck Clin Oncol (R Coll Radiol (Great Britain)) 17 2005 148 152